ChrNet
ChrNet predicts immune cell types from single-cell RNA sequencing (scRNA-seq) data by applying a chromosome-based one-dimensional convolutional neural network that incorporates gene positional information aligned to chromosomes.
Key Features:
- Chromosome-specific gene positional encoding: Incorporates gene positional data aligned to chromosomes as input context for classification.
- One-dimensional convolutional neural network (1D-CNN): Uses a chromosome-based 1D-CNN architecture to learn spatial patterns along chromosomes.
- Re-trainable supervised learning: Implements a supervised, re-trainable classifier to adapt to labeled datasets.
- Supports scRNA-seq data: Designed to process single-cell RNA sequencing (scRNA-seq) datasets for cell type prediction.
- Improved classification performance: Demonstrates benchmarked accuracy of over 90% in immune cell type profiling.
- Addresses unsupervised clustering variability: Provides a consistent classification alternative to unsupervised clustering methods that can yield variable results depending on input parameters and dataset size.
Scientific Applications:
- Immune cell type profiling: Classifies immune cell types from scRNA-seq data for single-cell studies.
- Tumor microenvironment analysis: Profiles immune composition within tumor microenvironments to inform biological interpretation.
- Cancer research and clinical inference: Supports analyses relevant to cancer prognosis and therapeutic strategy by improving immune cell identification in cancer tissues.
Methodology:
Incorporates gene positional data aligned to chromosomes into inputs and applies a chromosome-based 1D-CNN as a re-trainable supervised classifier on scRNA-seq datasets.
Topics
Details
- License:
- MIT
- Tool Type:
- command-line tool
- Programming Languages:
- Python
- Added:
- 6/14/2021
- Last Updated:
- 8/20/2021
Operations
Publications
Jia S, Hu P. ChrNet: A re-trainable chromosome-based 1D convolutional neural network for predicting immune cell types. Genomics. 2021;113(4):2023-2031. doi:10.1016/j.ygeno.2021.04.037. PMID:33932523.
PMID: 33932523
Funding: - Natural Sciences and Engineering Research Council of Canada: RGPIN-2021-04072